Marcos Ballester
Marcos Ballester is an expert in Gynecology at Assistance Publique - Hôpitaux de Paris (France). As of April 2026, ScienceLeadR ranks Marcos Ballester in the top 1% of experts worldwide for Uterine Diseases. Marcos Ballester has authored 246 publications, the most recent in 2024, and is an investigator in 8 clinical trials, 1 of them ongoing. SLR score: 610 (community average: 125). How the SLR is computed.
LeadR Profile
Gynecology
Subspecialties:
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2007 - 2024
Number : 246
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Author Correction: First external validity study of the Fagotti score in ovarian cancer. PMID 39138322 — neoplasms, ovarian neoplasms, natural science disciplines | Sci Rep | 2024 | 0 |
| First external validity study of the Fagotti score in ovarian cancer. PMID 38802436 — natural science disciplines, laparoscopy, ovarian neoplasms | Sci Rep | 2024 | 1 |
| [FRANCOGYN group: A brief history]. PMID 37839793 — genital diseases, female, neoplasms, research, history, pelvic neoplasms | Gynecol Obstet Fertil Senol | 2023 | 0 |
| Brachytherapy and surgery versus surgery alone for IB2 (FIGO 2018) cervical cancers: A FRANCOGYN study. PMID 37788511 — reproduction, lymph nodes, progression-free survival, hysterectomy, uterine cervical neoplasms, brachytherapy, neoplasms, obstetrics, lymph, gynecology, therapeutics | Eur J Obstet Gynecol Reprod Biol | 2023 | 2 |
| PARa-aOrtic LymphAdenectomy in locally advanced cervical cancer (PAROLA trial): a GINECO, ENGOT, and GCIG study. PMID 36717163 — lymph nodes, lymph node excision, therapeutics, uterine cervical neoplasms, positron-emission tomography, disease-free survival, genital neoplasms, female, positron emission tomography computed tomography | Int J Gynecol Cancer | 2023 | 16 |
Clinical Studies 8
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Ongoing Clinical Trials
Ongoing trial started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| PARa aOrtic LymphAdenectomy in Locally Advanced Cervical Cancer NCT05581121 — radiotherapy, carcinoma, adenosquamous, lymph nodes, lymph node excision, uterine cervical neoplasms, brachytherapy, neoplasms, adenocarcinoma, laparoscopy, human papillomavirus 16, lymph, therapeutics, carcinoma | Phase 3 | Recruiting | 2023 |
LeadR Networks
Main global connection map